Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis

Ahmed Guweidhi, Jörg Kleeff, Nathalia Giese, Jamael El Fitori, Knut Ketterer, Thomas Giese, Markus W. Büchler, Murray Korc, Helmut Friess

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

14-3-3sigma belongs to the 14-3-3 family of proteins, which are involved in the modulation of diverse signal transduction pathways. Loss of 14-3-3sigma expression has been observed in a number of human cancers, suggesting that it may have a role as a tumor suppressor gene. The aim of the study was to investigate the expression and the functional role of 14-3-3sigma in pancreatic ductal adenocarcinoma (PDAC). Expression of 14-3-3sigma was analyzed using laser capture microdissection (LCM), quantitative real-time-PCR (QRT-PCR), DNA arrays, immunohistochemistry and western blot analysis. The role of 14-3-3sigma in apoptosis and cell cycle regulation was evaluated by western blotting, immunoprecipitation and FACS analysis. By QRT-PCR, 14-3-3sigma mRNA levels were 54-fold increased in pancreatic adenocarcinoma in comparison with normal pancreatic samples and localized in pancreatic cancer cells as determined by LCM. In pancreatic cancer cells, the degree of 14-3-3sigma expression was not decisive for the maintenance of G2/M cell cycle check-point or induction of apoptosis. Responses to radiation or apoptosis-inducing agents were neither accompanied by a significant 14-3-3sigma accumulation nor by a change in association of 14-3-3sigma with cdc2, bad and bax. In conclusion, the marked over-expression of 14-3-3sigma in PADC together with multiple known genetic and epigenetic alterations of potential 14-3-3sigma interacting partners suggests an important role of aberrant 14-3-3sigma down-stream signaling in pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)1575-1585
Number of pages11
JournalCarcinogenesis
Volume25
Issue number9
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Laser Capture Microdissection
Cell Cycle
Apoptosis
Real-Time Polymerase Chain Reaction
Adenocarcinoma
Western Blotting
14-3-3 Proteins
Oligonucleotide Array Sequence Analysis
Tumor Suppressor Genes
Immunoprecipitation
Epigenomics
Signal Transduction
Immunohistochemistry
Maintenance
Radiation
Messenger RNA
Neoplasms

ASJC Scopus subject areas

  • Cancer Research

Cite this

Guweidhi, A., Kleeff, J., Giese, N., El Fitori, J., Ketterer, K., Giese, T., ... Friess, H. (2004). Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis, 25(9), 1575-1585. https://doi.org/10.1093/carcin/bgh159

Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. / Guweidhi, Ahmed; Kleeff, Jörg; Giese, Nathalia; El Fitori, Jamael; Ketterer, Knut; Giese, Thomas; Büchler, Markus W.; Korc, Murray; Friess, Helmut.

In: Carcinogenesis, Vol. 25, No. 9, 09.2004, p. 1575-1585.

Research output: Contribution to journalArticle

Guweidhi, A, Kleeff, J, Giese, N, El Fitori, J, Ketterer, K, Giese, T, Büchler, MW, Korc, M & Friess, H 2004, 'Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis', Carcinogenesis, vol. 25, no. 9, pp. 1575-1585. https://doi.org/10.1093/carcin/bgh159
Guweidhi, Ahmed ; Kleeff, Jörg ; Giese, Nathalia ; El Fitori, Jamael ; Ketterer, Knut ; Giese, Thomas ; Büchler, Markus W. ; Korc, Murray ; Friess, Helmut. / Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. In: Carcinogenesis. 2004 ; Vol. 25, No. 9. pp. 1575-1585.
@article{c5b1c578043248c4811e2d7aee1a89e3,
title = "Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis",
abstract = "14-3-3sigma belongs to the 14-3-3 family of proteins, which are involved in the modulation of diverse signal transduction pathways. Loss of 14-3-3sigma expression has been observed in a number of human cancers, suggesting that it may have a role as a tumor suppressor gene. The aim of the study was to investigate the expression and the functional role of 14-3-3sigma in pancreatic ductal adenocarcinoma (PDAC). Expression of 14-3-3sigma was analyzed using laser capture microdissection (LCM), quantitative real-time-PCR (QRT-PCR), DNA arrays, immunohistochemistry and western blot analysis. The role of 14-3-3sigma in apoptosis and cell cycle regulation was evaluated by western blotting, immunoprecipitation and FACS analysis. By QRT-PCR, 14-3-3sigma mRNA levels were 54-fold increased in pancreatic adenocarcinoma in comparison with normal pancreatic samples and localized in pancreatic cancer cells as determined by LCM. In pancreatic cancer cells, the degree of 14-3-3sigma expression was not decisive for the maintenance of G2/M cell cycle check-point or induction of apoptosis. Responses to radiation or apoptosis-inducing agents were neither accompanied by a significant 14-3-3sigma accumulation nor by a change in association of 14-3-3sigma with cdc2, bad and bax. In conclusion, the marked over-expression of 14-3-3sigma in PADC together with multiple known genetic and epigenetic alterations of potential 14-3-3sigma interacting partners suggests an important role of aberrant 14-3-3sigma down-stream signaling in pancreatic cancer.",
author = "Ahmed Guweidhi and J{\"o}rg Kleeff and Nathalia Giese and {El Fitori}, Jamael and Knut Ketterer and Thomas Giese and B{\"u}chler, {Markus W.} and Murray Korc and Helmut Friess",
year = "2004",
month = "9",
doi = "10.1093/carcin/bgh159",
language = "English (US)",
volume = "25",
pages = "1575--1585",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis

AU - Guweidhi, Ahmed

AU - Kleeff, Jörg

AU - Giese, Nathalia

AU - El Fitori, Jamael

AU - Ketterer, Knut

AU - Giese, Thomas

AU - Büchler, Markus W.

AU - Korc, Murray

AU - Friess, Helmut

PY - 2004/9

Y1 - 2004/9

N2 - 14-3-3sigma belongs to the 14-3-3 family of proteins, which are involved in the modulation of diverse signal transduction pathways. Loss of 14-3-3sigma expression has been observed in a number of human cancers, suggesting that it may have a role as a tumor suppressor gene. The aim of the study was to investigate the expression and the functional role of 14-3-3sigma in pancreatic ductal adenocarcinoma (PDAC). Expression of 14-3-3sigma was analyzed using laser capture microdissection (LCM), quantitative real-time-PCR (QRT-PCR), DNA arrays, immunohistochemistry and western blot analysis. The role of 14-3-3sigma in apoptosis and cell cycle regulation was evaluated by western blotting, immunoprecipitation and FACS analysis. By QRT-PCR, 14-3-3sigma mRNA levels were 54-fold increased in pancreatic adenocarcinoma in comparison with normal pancreatic samples and localized in pancreatic cancer cells as determined by LCM. In pancreatic cancer cells, the degree of 14-3-3sigma expression was not decisive for the maintenance of G2/M cell cycle check-point or induction of apoptosis. Responses to radiation or apoptosis-inducing agents were neither accompanied by a significant 14-3-3sigma accumulation nor by a change in association of 14-3-3sigma with cdc2, bad and bax. In conclusion, the marked over-expression of 14-3-3sigma in PADC together with multiple known genetic and epigenetic alterations of potential 14-3-3sigma interacting partners suggests an important role of aberrant 14-3-3sigma down-stream signaling in pancreatic cancer.

AB - 14-3-3sigma belongs to the 14-3-3 family of proteins, which are involved in the modulation of diverse signal transduction pathways. Loss of 14-3-3sigma expression has been observed in a number of human cancers, suggesting that it may have a role as a tumor suppressor gene. The aim of the study was to investigate the expression and the functional role of 14-3-3sigma in pancreatic ductal adenocarcinoma (PDAC). Expression of 14-3-3sigma was analyzed using laser capture microdissection (LCM), quantitative real-time-PCR (QRT-PCR), DNA arrays, immunohistochemistry and western blot analysis. The role of 14-3-3sigma in apoptosis and cell cycle regulation was evaluated by western blotting, immunoprecipitation and FACS analysis. By QRT-PCR, 14-3-3sigma mRNA levels were 54-fold increased in pancreatic adenocarcinoma in comparison with normal pancreatic samples and localized in pancreatic cancer cells as determined by LCM. In pancreatic cancer cells, the degree of 14-3-3sigma expression was not decisive for the maintenance of G2/M cell cycle check-point or induction of apoptosis. Responses to radiation or apoptosis-inducing agents were neither accompanied by a significant 14-3-3sigma accumulation nor by a change in association of 14-3-3sigma with cdc2, bad and bax. In conclusion, the marked over-expression of 14-3-3sigma in PADC together with multiple known genetic and epigenetic alterations of potential 14-3-3sigma interacting partners suggests an important role of aberrant 14-3-3sigma down-stream signaling in pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=4544269166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544269166&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgh159

DO - 10.1093/carcin/bgh159

M3 - Article

VL - 25

SP - 1575

EP - 1585

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -